NASDAQ:BNTC

Benitec Biopharma Earning Date

USA |NASDAQ |USD

BNTC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 11, 2021 Sep 2021 $0.00 $-0.49 $-2.72
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 11, 2021 Sep 2021 $0.00 $2.00K $55.00K

Benitec Biopharma's next earnings date is Thursday, Nov 11, 2021 for the fiscal quarter ending Sep 2021.

BNTC Earnings Date & History Chart

BNTC Earnings & Revenue Forecast

BNTC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 0 $0.00 $0.00 $0.00
Jun 2023 0 $0.00 $0.00 $0.00

BNTC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 0 $0.00 $0.00 $0.00
Jun 2023 0 / 0 $0.00 $0.00 $0.00

BNTC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 0 $0.00 $0.00 $0.00
Jun 2023 0 $0.00 $0.00 $0.00

BNTC Earnings Date & Revenue History

BNTC Earnings History

|
Show More
Show More

BNTC Revenue History

|
Show More
Show More

Benitec Biopharma Next Earnings Date & Report

BNTC Next Earnings Date & Report Preview: Sep 2021 (FQ)

BNTC's next earnings date is Thursday, Nov 11, 2021 for the fiscal quarter ending Sep 30, 2021.

According to analysts, the average EPS estimation for Benitec Biopharma's next quarterly earnings is $0.00, with a low EPS estimation of $0.00, and a high estimation of $0.00.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.00, the last 2 month trend is $0.00, and the 3 month trend is $0.00.

Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Benitec Biopharma Previous Earnings Dates & Reports

BNTC Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Benitec Biopharma's previous earnings date was Sep 20, 2021 for its fiscal quarter ended Jun 30, 2021.

BNTC's earnings per share (EPS) was $-0.49.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -40.51%, and higher than the same period a year before (Jun 2020) by -75.03%.

Revenues were $2.00K.

The company reported a net income of $-4.00M.

Free cash flow for the quarter was $-5.02M , compared to $-2.00M last quarter and $-3.16M a year before.

BNTC ended the quarter with $213.00K in total debt, a decrease of -18.70% compared to the previous quarter, and an increase of 110837.50% compared to the same quarter a year before.

BNTC Previous Earnings Date & Report Recap: Jun 2021 (FY)

Benitec Biopharma's previous annual earnings date was Sep 20, 2021 for its fiscal year ended Jun 30, 2021.

BNTC's earnings per share (EPS) was $-4.79, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Jun 2020) by -41.85%.

Revenues were $59.00K, worse than the forecast of $110.00K by -46.36%, and down by -39.18% from previous year's revenue.

The company reported a net income of $-13.88M.

Benitec Biopharma reported a free cash flow of $-13.05M for its fiscal year, compared to $-7.63M a year ago.

The company ended the fiscal year with $213.00K in total debt, a decrease of -47.41% compared to the previous year.